What is Apyx Medical Corporation's D&A?

Apyx Medical Corporation (APYX) reported D&A of $202K in Q1 2026.

How has Apyx Medical Corporation's D&A changed year-over-year?

Apyx Medical Corporation's D&A increased by 46.4% year-over-year, from $138K to $202K.

What is the long-term trend for Apyx Medical Corporation's D&A?

Over 4 years (2021 to 2025), Apyx Medical Corporation's D&A has grown at a -7.7% compound annual growth rate (CAGR), from $903K to $655K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Apyx Medical Corporation APYX D&A

D&A at other companies

Bausch Health CompaniesBHC

$295M-3.3%

ArtivionAORT

$6.34M+16.4%

AngioDynamicsANGO

$5.59M-11.5%

AIR

AirSculpt Technologies, Inc.AIRS

$3.02M-6.8%

PROCEPT BioRobotics CorporationPRCT

$1.74M+17.6%

AtriCureATRC

$2.89M-2.9%

Other financials

Income statement

See full

Revenue$12.5M+32.4%

Gross profit$7.5M-19.2%

Operating income-$5.5M-349%

Net income-$2.1M+48.6%

EPS (diluted)-$0.19-533%

Balance sheet

See full

Cash & equivalents$31.1M+0.4%

Total debt$39.5M+1.4%

Total equity$12.8M+22.1%

Total assets$63.0M+4.8%

Cash flow

See full

Operating cash flow-$572.0K+18.5%

CapEx$60.0K+9.1%

Free cash flow-$632.0K+16.5%

Valuation

See full

Market cap$181.07M+114%

Enterprise value$189.4M+101%

P/S3.2×+1.4×

Profitability

See full

Gross margin61.9%-3.1pp

Operating margin-46%+9.9pp

Net margin-16.2%-6.2pp

FCF margin-16.1%-4.8pp

Returns & leverage

See full

Return on equity-77.8%-22.4pp

Debt / equity3.1×-0.6×

Current ratio5.8×+0.3×

Where this comes from

Reported directly by Apyx Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Apyx Medical Corporation's D&A?: Apyx Medical Corporation (APYX) reported D&A of $202K in Q1 2026.
How has Apyx Medical Corporation's D&A changed year-over-year?: Apyx Medical Corporation's D&A increased by 46.4% year-over-year, from $138K to $202K.
What is the long-term trend for Apyx Medical Corporation's D&A?: Over 4 years (2021 to 2025), Apyx Medical Corporation's D&A has grown at a -7.7% compound annual growth rate (CAGR), from $903K to $655K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.